These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6168129)
21. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. Nau H; Rating D; Koch S; Häuser I; Helge H J Pharmacol Exp Ther; 1981 Dec; 219(3):768-77. PubMed ID: 6795343 [TBL] [Abstract][Full Text] [Related]
22. [Drugs during perinatal period: placental passage and excretion in breast milk (author's transl)]. Dolphen R; Lesne M J Pharm Belg; 1980; 35(4):311-9. PubMed ID: 7441481 [No Abstract] [Full Text] [Related]
23. [Detection of caffeine, theophylline and theobromine in the umbilical cord blood and breast milk]. Bucher HU; Gautschi K Helv Paediatr Acta; 1985 Jul; 40(2-3):163-7. PubMed ID: 3855177 [TBL] [Abstract][Full Text] [Related]
24. Drugs used with neonates and during pregnancy. Part 3: drugs that may cause fetal damage or cross into breast milk. Overbach AM RN; 1974 Dec; 37(12):39-45. PubMed ID: 4497282 [No Abstract] [Full Text] [Related]
25. Relationship between the acetylator phenotype, plasma sulfapyridine levels and adverse effects during treatment with salicylazosulfapyridine in patients with chronic bowel diseases. Rahav G; Zylber-Katz E; Rachmilewitz D; Levy M Isr J Med Sci; 1990 Jan; 26(1):31-4. PubMed ID: 1968894 [TBL] [Abstract][Full Text] [Related]
26. Bilirubin binding capacity of albumin isolated from cord-blood serum is less than that from serum of adults. Alayoff A; Kapitulnik J; Konijn A; Kaufmann NA; Blondheim SH Clin Chem; 1980 May; 26(6):738-40. PubMed ID: 7371151 [TBL] [Abstract][Full Text] [Related]
27. High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites. Its application for pharmacokinetic studies with salicylazosulfapyridine in man. Fischer C; Klotz U J Chromatogr; 1979 Feb; 162(2):237-43. PubMed ID: 33196 [No Abstract] [Full Text] [Related]
28. [Albumin-bilirubin binding in premature and newborn infants]. Windorfer A Fortschr Med; 1976 Mar; 94(8):448-50. PubMed ID: 964902 [No Abstract] [Full Text] [Related]
29. Maternal-fetal transfer of metallic mercury via the placenta and milk. Yang J; Jiang Z; Wang Y; Qureshi IA; Wu XD Ann Clin Lab Sci; 1997; 27(2):135-41. PubMed ID: 9098513 [TBL] [Abstract][Full Text] [Related]
30. The effect of rifampicin on sulphapyridine plasma concentrations following sulphasalazine administration. Shaffer JL; Houston JB Br J Clin Pharmacol; 1985 Apr; 19(4):526-8. PubMed ID: 2859874 [No Abstract] [Full Text] [Related]
31. [Tissue and body fluid distribution of antibacterial agents in pregnant and lactating women]. Zhang Y; Zhang Q; Xu Z Zhonghua Fu Chan Ke Za Zhi; 1997 May; 32(5):288-92. PubMed ID: 9596854 [TBL] [Abstract][Full Text] [Related]
32. Orocecal transit time in humans assessed by sulfapyridine appearance in saliva after sulfasalazine intake. Dhôte R; Bergmann JF; Leglise P; Chassany O; Elkharrat D; Conort O; Caulin C Clin Pharmacol Ther; 1995 Apr; 57(4):461-70. PubMed ID: 7712676 [TBL] [Abstract][Full Text] [Related]
33. Exposure of the fetus and infant to hens' egg ovalbumin via the placenta and breast milk in relation to maternal intake of dietary egg. Vance GH; Lewis SA; Grimshaw KE; Wood PJ; Briggs RA; Thornton CA; Warner JO Clin Exp Allergy; 2005 Oct; 35(10):1318-26. PubMed ID: 16238791 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of potential neuro-toxic effect of circulating bilirubin during neonatal period: I. Analytical comparison between residual binding capacity of albumin (R.B.C.A.) and saturation index (S.I.)]. Priolisi A; Zino L Pediatria (Napoli); 1970 Dec; 78(6):983-1007. PubMed ID: 5535194 [No Abstract] [Full Text] [Related]
35. The epileptic mother and her child. Philbert A; Dam M Indian Pediatr; 1983 Nov; 20(11):811-24. PubMed ID: 6373603 [No Abstract] [Full Text] [Related]
36. Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide. Nanovskaya TN; Patrikeeva S; Hemauer S; Fokina V; Mattison D; Hankins GD; Ahmed MS; J Matern Fetal Neonatal Med; 2008 Mar; 21(3):197-207. PubMed ID: 18297575 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous determination of sulfasalazine and its metabolites sulfapyridine and N-acetylsulfapyridine in human serum by ion-pair high-performance liquid chromatography using a polymer-based column. Buggé CJ; Gautam SR; Parke LE; Mason JT; Garcia DB J Pharm Sci; 1990 Dec; 79(12):1095-8. PubMed ID: 1981912 [TBL] [Abstract][Full Text] [Related]
38. Reserve bilirubin binding capacity measured by absorbance deviation at saturation of primary albumin binding sites. Banagale RC; Bernstein LH Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):463-79. PubMed ID: 7163638 [TBL] [Abstract][Full Text] [Related]
39. Drug therapy: Sulfasalazine. Goldman P; Peppercorn MA N Engl J Med; 1975 Jul; 293(1):20-3. PubMed ID: 236516 [No Abstract] [Full Text] [Related]